These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16392037

  • 1. Quantitation of O6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas.
    Tanaka S, Oka H, Fujii K, Watanabe K, Nagao K, Kakimoto A.
    Cell Mol Neurobiol; 2005 Sep; 25(6):1067-71. PubMed ID: 16392037
    [Abstract] [Full Text] [Related]

  • 2. O6-methylguanine-DNA methyltranspherase gene expression in gliomas by means of real-time quantitative RT-PCR and clinical response to nitrosoureas.
    Tanaka S, Kobayashi I, Utsuki S, Oka H, Fujii K, Watanabe T, Nagashima T, Hori T.
    Int J Cancer; 2003 Jan 01; 103(1):67-72. PubMed ID: 12455055
    [Abstract] [Full Text] [Related]

  • 3. Individual adjuvant therapy for malignant gliomas based on O6-methylguanine-DNA methyltransferase messenger RNA quantitation by real-time reverse-transcription polymerase chain-reaction.
    Tanaka S, Akimoto J, Kobayashi I, Oka H, Ujiie H.
    Oncol Rep; 2008 Jul 01; 20(1):165-71. PubMed ID: 18575733
    [Abstract] [Full Text] [Related]

  • 4. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
    Tanaka S, Akimoto J, Narita Y, Oka H, Tashiro T.
    J Neurosurg; 2014 Oct 01; 121(4):818-26. PubMed ID: 25105699
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
    Tanaka S, Kobayashi I, Utsuki S, Oka H, Yasui Y, Fujii K.
    Oncol Rep; 2005 Nov 01; 14(5):1275-80. PubMed ID: 16211296
    [Abstract] [Full Text] [Related]

  • 6. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
    Tanaka S, Kamitani H, Amin MR, Watanabe T, Oka H, Fujii K, Nagashima T, Hori T.
    J Neurooncol; 2000 Nov 01; 46(2):157-71. PubMed ID: 10894369
    [Abstract] [Full Text] [Related]

  • 7. O6-methylguanine-DNA methyltransferase activity in cerebral gliomas. A guidance for nitrosourea treatment?
    Mineura K, Izumi I, Kuwahara N, Kowada M.
    Acta Oncol; 1994 Nov 01; 33(1):29-32. PubMed ID: 8142120
    [Abstract] [Full Text] [Related]

  • 8. Influence of O6-methylguanine-DNA methyltransferase activity on chloroethylnitrosourea chemotherapy in brain tumors.
    Mineura K, Izumi I, Watanabe K, Kowada M.
    Int J Cancer; 1993 Aug 19; 55(1):76-81. PubMed ID: 8393842
    [Abstract] [Full Text] [Related]

  • 9. Expression of O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors.
    Nagane M, Asai A, Shibui S, Nomura K, Matsutani M, Kuchino Y.
    Jpn J Clin Oncol; 1992 Jun 19; 22(3):143-9. PubMed ID: 1518162
    [Abstract] [Full Text] [Related]

  • 10. Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas.
    Nagane M, Asai A, Shibui S, Nomura K, Kuchino Y.
    Neurosurgery; 1997 Aug 19; 41(2):434-40; discussion 440-1. PubMed ID: 9257312
    [Abstract] [Full Text] [Related]

  • 11. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
    Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL.
    J Clin Oncol; 2006 Jul 20; 24(21):3431-7. PubMed ID: 16849758
    [Abstract] [Full Text] [Related]

  • 12. Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter.
    Chen ZP, Pan J, Huang Q, Sun ZF, Zhou LY, Wang AD.
    J Neurooncol; 2001 Jan 20; 51(1):19-24. PubMed ID: 11349876
    [Abstract] [Full Text] [Related]

  • 13. Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains.
    Mineura K, Fushimi S, Kowada M, Isowa G, Ishizaki K, Ikenaga M.
    Acta Neurochir (Wien); 1990 Jan 20; 103(1-2):62-6. PubMed ID: 2360469
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
    Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG.
    N Engl J Med; 2000 Nov 09; 343(19):1350-4. PubMed ID: 11070098
    [Abstract] [Full Text] [Related]

  • 15. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
    Sato K, Kitajima Y, Koga Y, Miyazaki K.
    Anticancer Res; 2005 Nov 09; 25(6B):4021-8. PubMed ID: 16309194
    [Abstract] [Full Text] [Related]

  • 16. Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea-based chemotherapy.
    Kamiryo T, Tada K, Shiraishi S, Shinojima N, Kochi M, Ushio Y.
    Neurosurgery; 2004 Feb 09; 54(2):349-57; discussion 357. PubMed ID: 14744281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
    Fukuchi M, Mineura K, Kowada M, Terashima I, Kohda K.
    No To Shinkei; 1997 Jun 09; 49(6):521-8. PubMed ID: 9198092
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
    Sato K, Kitajima Y, Nakagawachi T, Soejima H, Miyoshi A, Koga Y, Miyazaki K.
    Oncol Rep; 2005 May 09; 13(5):899-906. PubMed ID: 15809756
    [Abstract] [Full Text] [Related]

  • 20. Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea.
    Manome Y, Yoshinaga H, Watanabe M, Ohno T.
    Anticancer Res; 2002 May 09; 22(4):2029-36. PubMed ID: 12174880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.